What is Lyme disease and how is it transmitted?
Lyme disease is a tick-borne infection caused by the spirochete bacterium Borrelia burgdorferi. The disease is transmitted by Ixodes tick bites, primarily in spring and early summer when nymphal tick populations are highest. Because nymphs are tiny — about the size of a poppy seed — many people are bitten without noticing.
Lyme is endemic across Europe, the UK, and northeastern North America. Emergence in parts of Australia has also been documented. For outdoor enthusiasts, hikers, and rural residents, awareness and tick prevention are essential.
Early vs. late Lyme disease presentations
Early Lyme disease appears days to weeks after infection. The hallmark sign is erythema migrans (EM) — a distinctive expanding rash often resembling a bull's-eye, though not always present. Patients may experience fever, chills, muscle aches, and fatigue mimicking flu.
If untreated, late Lyme disease develops over months and may include arthritis (especially affecting knees), neuroborreliosis (neurological involvement), carditis (cardiac inflammation), and chronic dermatitis. Early antibiotic treatment with doxycycline or amoxicillin is highly effective, while late disease requires longer treatment courses and carries greater risk of complications.
IgM vs. IgG antibodies and timing of testing
The body's immune response to Borrelia infection unfolds in stages. IgM antibodies appear first, typically 1-2 weeks after infection, peaking around 3-6 weeks. IgG antibodies develop later, appearing around 2-3 weeks and persisting for months or years, even after successful treatment.
Testing timing matters: testing too early (before antibodies develop) produces false negatives, creating diagnostic delay. This is why the CDC recommends against testing for Lyme within the first 2 weeks unless erythema migrans is already present. Once antibodies are detectable, the clinical picture becomes clearer.
Why two-tier testing is the standard of care
Two-tier testing uses ELISA (enzyme-linked immunosorbent assay) as the initial screen, followed by Western blot confirmation for positive or equivocal results. This approach balances sensitivity and specificity: ELISA catches most true infections, while Western blot confirms diagnosis and minimizes false positives from cross-reactive antibodies.
Single-tier testing using ELISA alone has insufficient specificity for clinical decision-making, as other infections and autoimmune conditions can cross-react. Two-tier protocols are endorsed by the CDC and are the evidence-based standard globally.
Dried blood spot Borrelia antibody testing
Masdiag's Borrelia IgM and IgG test uses ELISA from dried blood spots collected via finger prick. The dried sample is stable during postal transit, eliminating the need for refrigeration and transportation to a clinic for venipuncture.
This approach makes screening more accessible for people in endemic areas, those with recent tick exposures, or those living remotely. Positive results can then be confirmed with Western blot through appropriate channels, enabling a complete diagnostic pathway without requiring clinic visits for the initial screening step.
Limitations and interpretation
No serological test is perfect. Early infection (before 2-3 weeks) may test negative despite symptoms. Conversely, past infection or successful treatment can show positive IgG for years, making serology alone insufficient for distinguishing active from past infection in some cases.
Clinical context matters: recent tick exposure, characteristic symptoms, and appropriate timing of testing all inform interpretation. In endemic areas with high pretest probability, positive IgM warrants consideration of early treatment even before Western blot confirmation in appropriate clinical scenarios. Always work with a healthcare provider for diagnosis and management.
Frequently asked questions
What causes Lyme disease and where is it found?
Lyme disease is caused by the spirochete bacterium Borrelia burgdorferi, transmitted by infected Ixodes tick bites. It's endemic in Europe, the UK, northeastern United States, and emerging in parts of Australia. Risk is highest in spring and early summer when nymphal ticks (easily missed due to size) are most active.
What's the difference between early and late Lyme disease?
Early Lyme disease (localized or disseminated) presents days to weeks after infection with erythema migrans rash and flu-like symptoms. Late Lyme disease appears months later and includes arthritis (especially knee), neuroborreliosis (neurological), and carditis (cardiac). Early treatment with antibiotics is highly effective; late disease requires longer courses.
What is two-tier testing and why is it standard?
Two-tier testing uses ELISA as the first screen (high sensitivity) followed by Western blot confirmation for positive or indeterminate results (high specificity). This approach minimizes false positives from cross-reactive antibodies while catching true infections. Single-tier testing is generally not recommended due to lower specificity.
Explore This Test
View the full method details, sample requirements, and analytical specifications for our Borrelia IgM and IgG antibody test.
View Borrelia Testing Method →